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Objective: To investigate the effect of interpregnancy interval (IPI) on preterm birth (PTB) 
according to whether the previous birth was preterm or term. 
Design: Cohort study. 
Setting: USA (California), Australia, Finland, Norway (1980-2017). 
Population: Women who gave birth to first and second (N=3,213,855) singleton livebirths. 
Methods: Odds ratios (ORs) for PTB according to IPIs were modelled using logistic 
regression with prognostic score stratification for potential confounders. Within-site ORs 
were pooled by random-effects meta-analysis.  
Outcome Measure: PTB (gestational age<37 weeks).  
Results: Absolute risk of PTB for each IPI ranged from 3-6% after previous term and 17-
22% after previous PTB. ORs for PTB differed between previous term and preterm births in 
all countries (P-for-interaction≤0.001). For women with a previous term birth, pooled ORs 
were increased for IPI <6months (1.50, 95%CI 1.43-1.58); 6-11months (1.10, 95%CI 1.04-
1.16); 24-59months (1.16, 95%CI 1.13-1.18); and ≥60months (1.72, 95%CI 1.60-1.86), 
compared to 18-23months. For previous PTB, ORs were increased for <6months (1.30, 
95%CI 1.18-1.42) and ≥60months (1.29, 95%CI 1.17-1.42), but were less than ORs among 
women with a previous term birth (P<0.05). 
Conclusions: Associations between IPI and PTB are modified by whether the previous 
pregnancy was preterm. ORs for short and long IPIs were higher among women with a 
previous term birth than a previous PTB, which for short IPI is consistent with the maternal 
depletion hypothesis. Given high risk of recurrence and assuming a causal association 
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between IPI and PTB, IPI remains a potentially modifiable risk factor for women with 
previous PTB. 
Funding: NHMRC (Australia); MRC (UK); Research Council of Norway; March of Dimes 
Prematurity Research Center, NIH (US). 
Keywords: interpregnancy interval; preterm birth; effect modification. 
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Interpregnancy interval (IPI), the length of time between pregnancies, has been identified as a 
potentially modifiable risk factor for adverse outcomes in infants and their mothers, with both 
short and long IPIs found to be associated with a range of adverse pregnancy outcomes.1,2 To 
reduce the risk of adverse birth outcomes, the World Health Organization (WHO) recommends 
waiting at least two years following a live birth and six months following a miscarriage or 
induced abortion, before conceiving another child.3 However, there is emerging evidence that 
the effects of IPI may differ according to obstetric history.1,4,5 A meta-analysis of a million 
women with previous miscarriage found that IPI of <6 months was not associated with adverse 
outcomes in the subsequent pregnancy.1 Recently, an international cohort study observed no 
increase in risk of adverse outcomes for short IPIs in women with a previous pregnancy ending 
in stillbirth.4 These findings suggest that the current recommendations may oversimplify 
associations between IPI and adverse pregnancy outcomes; recommendations tailored 
according to obstetric history may be a more efficient way of communicating potential risks 
associated with birth spacing. 
Studies examining the effect of IPI following live births6 have indicated that short IPI (<6 
months) was associated with a nearly two-fold increase in the odds of preterm birth (PTB). 
Given there is also a strong recurrence risk of PTB,7 information on whether previous preterm 
birth may modify the association between IPI and risk of PTB in the subsequent pregnancy is 
sparse.8 The aim of this study was to determine whether the association between IPI and PTB 
was modified by whether the previous birth was preterm. In addition, we planned to estimate 
absolute risks of PTB associated with short or long IPI, to better inform decision-making 






We conducted a multi-country, longitudinal cohort study of women with consecutive singleton 
livebirths in California, USA (1991-2012); Western Australia (WA) (1980-2015); New South 
Wales (NSW), Australia (1995-2012); Norway (1980-2015); and Finland (1987-2017) 
(N=14,760,447 births). We obtained individual-level records from population-based birth and 
perinatal registries with >99% coverage in each site.9-13 Data sources have been described in 
the previously published protocol.14 Briefly, the extracted records included information on 
maternal age and infant’s date of birth, gestational age, birthweight, birth order and vital status 
at birth. We excluded births with missing gestational age, birthweight, or date of birth. In 
addition, we excluded births where gestational age was recorded as <20 or ≥45 weeks, and 
women aged <14 years.15 Records with a negative IPI were also excluded. 
Assessment of interpregnancy interval 
Interpregnancy interval was calculated as the time between the end of one pregnancy (birth 
date) and the start of the next pregnancy (birth date pertaining to next pregnancy minus 
gestational age at birth). Gestational age at birth was estimated based on ultrasound dating, or 
last menstrual period when ultrasound was not available. For comparison with WHO 
recommendations,3 we defined six levels of IPI: <6 months (“short” IPI), 6-11 months, 12-17 
months, 18-23 months, 24-59 months, and ≥60 months (“long” IPI). 
Birth outcome measures 
The primary outcome was PTB, defined as a pregnancy ending at <37 completed weeks’ 
gestation. A literature search did not identify a core outcome set for IPI exposure. However, 





Within-site analyses were first restricted to the cohort defined by the first and second 
consecutive livebirths (parity 0, 1), and repeated using the second and third consecutive 
livebirths (parity 1, 2). We used conditional (prognostic score-stratified) logistic regression to 
model PTB as the outcome, and IPI category, previous term or preterm birth status, and their 
multiplicative interaction as predictors. Statistical significance of the interaction was assessed 
by an overall Wald test. Prognostic scores16 were derived from within-site logistic regression 
of PTB as the outcome on maternal age (14-19, 20-24, 25-29, 30-34, 35-39, or ≥40 years) and 
year of birth as predictors to account for confounder imbalance. Strata for conditional models 
were defined by five percentile increments in prognostic score. 
Supplementary analyses included an additional variable for socioeconomic status (SES) in 
prognostic score models. For California, SES was assessed as level of education (some high 
school or less; high school diploma or equivalent; some college; college graduate or more). For 
Australia (WA, NSW), SES was derived from the Australian Bureau of Statistics Index of 
Relative Socioeconomic Disadvantage, a geographic area-level composite of education, skilled 
occupation status, and household income.17 For Finland, SES was based on occupation during 
pregnancy recorded at birth (upper white collar; lower white collar; blue collar; others 
including students, housewives and unknown SES).18 The Norwegian cohort did not have 
measures of SES and was therefore excluded from supplementary analyses. 
Adjusted odds ratios (aORs) for PTB (at second birth) and their associated 95% confidence 
intervals (CIs) were estimated for each IPI category using an IPI of 18-23 months as the referent 
group, and calculated by previous preterm birth status (at first birth). Within-site aORs were 
pooled using the inverse variance method with random intercepts for countries (Revman 5.3).19 
The Cochrane Q statistic was used to test for differences in aORs between women with 
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previous term and preterm birth, within each IPI category.20 Heterogeneity was quantified by 
the I2 statistic.21 Crude absolute risks for PTB were derived within-countries for each IPI 
category, stratified by previous term birth (incident risk) and preterm birth (recurrence risk). 
Pooled absolute risks were computed using logistic regression models with random intercepts 
for countries (SAS 9.4, SAS Institute, Cary, NC). All tests were two-sided, and statistical 
significance was defined as P<0.05. 
Patient involvement 
A reference group of consumer health representatives (Healthy Pregnancies Reference Group) 
was established, comprising women with lived experience of pregnancy with adverse birth 
outcomes. The group met twice-yearly to provide a community perspective on this research, 
providing advice regarding research aims; language, including lay summaries; links between 
consumers, the community, and the researchers; and advocacy on behalf of consumers and the 
community. The reference groups also contributed to interpretation of the findings by 
identifying factors that may influence IPI.14  
Details of study funding 
The study sponsors had no role in study design; in the collection, analysis, and interpretation 
of data; in the writing of the report; and in the decision to submit the paper for publication. The 
corresponding author had full access to all the data in the study and had final responsibility for 





From a cohort of 14,760,447 births, we identified 3,574,889 women with their first two 
consecutive singleton births (parity 0, 1) in the study period (1980-2017); of these, 3,213,855 
(89.9%) met eligibility criteria and were included in the analytic cohort (Table 1).  
In all countries, the distribution of age at birth of the second child peaked between 25 and 34 
years. For second births, 187,270 (5.8%) were PTBs, of which just over half (n=101,422) were 
spontaneous PTBs. The occurrence of PTB varied by study site, with the greatest incidence in 
California (7.9%, Table 1). Overall, 216,197 women (6.7%) had a PTB in their first pregnancy. 
IPIs were most commonly within the WHO-recommended range of 24-59 months (37.0%) 
(Figure 1); 4.8% and 11.1% of women had IPIs <6 months and ≥60 months, respectively. 
Distributions of IPIs were similar for women with a previous preterm or previous term birth 
(Table S1). 
As a supplementary analysis, we identified 1,332,854 women with second and third 
consecutive singleton livebirths (parity 1, 2), of which 1,146,545 (86.7%) met eligibility 
criteria (Table S2). For third births, 68,990 (6.0%) were PTBs, of which just over half 
(n=36,929) were spontaneous PTBs. Overall, 62,912 (5.5%) had a history of a PTB in the 
second pregnancy (Table S2). The most common IPI after a second birth was 24-59 months 
(39.1%) (Figure S1). 
Effect estimates of interpregnancy interval on preterm birth by previous preterm birth status 
Site-specific analyses 
For all countries, the cohort analysis of first and second births showed an interaction between 
the effects of IPI and previous preterm birth on the odds of PTB (P-for-interaction ≤0.001 for 
all within-site analyses; Tables S3-S7). Qualitatively, there were similar relationships between 
IPI and odds of PTB in each site. For women with a previous term birth, there was a “U-shaped” 
association between IPI and the aOR of PTB, with greater aORs for IPIs of <6 months and ≥60 
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months compared with 18-23 months. For women whose prior pregnancy ended in a preterm 
birth, aORs in all countries were lower than for women with a previous term birth for IPIs of 
<6 months (except Norway, where the aORs were similar) and ≥60 months. 
Site-specific analyses of second and third births were similar (Tables S3-S7). Greater instability 
among point estimates was observed in the latter analyses due to smaller numbers. 
Pooled analyses 
When site-specific results were pooled for women with previous term birth, aORs for 
subsequent PTB were elevated for IPIs of <6 months (1.50, 95% CI 1.43-1.58); 6-11 months 
(1.10, 95% CI 1.04-1.16); 24-59 months (1.16, 95% CI 1.13-1.18); and ≥60 months (1.72, 95% 
CI 1.60-1.86), compared to 18-23 months (Figure 2, panel A; Table 2). For women with 
previous preterm birth, pooled aORs for IPIs of <6 months (1.30, 95% CI 1.18-1.42); 6-11 
months (1.03, 95% CI 0.98-1.07); and ≥60 months (1.29, 95% CI 1.17-1.42) were lower than 
those for women with previous term births. 
Results were similar when analyses were repeated using the cohort of second and third births 
(Table S8). The inclusion of SES in prognostic score stratification (when available) did not 
change the results. Odds ratios closely approximated relative risks for unadjusted analyses 
(Table S9).                                                                                                                                                                                              
Absolute risk of preterm birth by interpregnancy interval category and previous preterm birth 
status 
Within-site analyses of first and second births consistently found that for each IPI category, the 
absolute risk of a preterm second birth was higher for women with a previous preterm than a 
previous term birth (Tables S10-S14). For all IPIs, pooled absolute risks of PTB ranged 
between 3 and 6% (incidence) for previous term birth and 17 to 22% (recurrence) for previous 
preterm birth, with highest risks at IPIs <6 or >60 months and lowest at 18-23 months (Figure 
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2, panel B; Table 3). Compared with 18-23 months, absolute risk differences for IPIs of <6 and 
>60 months were 2.0% and 2.3% (respectively) for women with previous term births, and 5.4% 
and 4.0% for women with previous preterm births. Similar results were observed for third births 
(Tables S9-S13). Pooled absolute risks of preterm third birth were 4-6% in those with term 
second birth versus 22-29% if the previous birth was preterm (Table S15). 
Discussion 
Main findings 
In this large international cohort assembled over an almost 40-year period (1980-2017), we 
observed an increase in the odds of PTB for both short and long intervals compared with an 
interval of 18-23 months. Previous studies have observed similar relative increases in risk for 
short1,2 and long IPI15,22; however, our results showed that those relative increases are lower if 
the previous pregnancy was preterm. For IPIs <6 months and ≥60 months, the OR of PTB was 
greater among women with a previous term birth compared with a previous preterm birth.  
Strengths and limitations 
A strength of our analyses was that we included adjustment for some potential confounders by 
prognostic score stratification, allowing for tighter control of confounding than conventional 
adjustment, and ensuring that temporal covariates (e.g. birth year) do not recreate the IPI.23 
This approach also has the advantage of approximating a mother-matched design without 
restriction of the cohort to women with three or more births, and therefore has greater 
applicability to the population of women for whom IPI is relevant.24 However, this design 
cannot account for time-invariant confounding as effectively as a mother-matched design (the 
latter was not possible for this study question due to the same PTB event being both an outcome 
for the first IPI and an effect modifier for the second IPI). To maintain comparability between 
sites, our analysis had a limitation in the number of covariates that could be included in 
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prognostic score models (maternal age, year of birth, SES). Furthermore, unmeasured variables 
such as pregnancy intention or smoking have the potential to confound the association between 
IPI and birth outcomes,25 and may vary according to whether the preceding birth was preterm 
or term. Given that the distribution of gestational length may vary by racial or ethnic 
background, future research should explore whether this further modifies the observed 
associations.24 
Our study was based on large individual participant data sets from four high-income countries. 
Although our published study protocol invited collaboration,14 we did not attempt to include 
all data sets that may be relevant to addressing our question. It is possible that other data sources 
may have been informative. No previous studies have explored the interaction between IPI and 
previous preterm birth, and hence no additional study-level data was available to contribute to 
our estimates. 
An additional limitation of our study relates to assessment of gestational age at birth. This was 
measured primarily by ultrasound, but the measurement method was recorded inconsistently 
in the source data sets, and hence we could not estimate the proportion of births without 
sonographic measurement. Misclassification of preterm birth is possible when gestational 
length was estimated by last menstrual period. 
Interpretation 
A recent study investigated the effect of IPI on birth outcomes in a cohort of women with a 
previous spontaneous preterm birth.26 Consistent with our study, odds of subsequent PTB in 
that restricted cohort were increased for both short (<6 months) and long (≥60 months) IPIs 
relative to an IPI of 18-23 months. However, the magnitudes of association were greater than 
our estimates (OR 2.22 versus 1.30 for short IPI; OR 2.19 versus 1.72 for long IPI). This may 
reflect the cohort restricted to previous spontaneous PTB for whom the biological effect of IPI 
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may be greater than after any (spontaneous or iatrogenic) PTB. Nonetheless, that previous 
study did not allow the effect of IPI to be compared with women who had a previous term birth. 
By not applying such restriction, our study overcomes this limitation to investigate the 
interaction between IPI and previous preterm birth, showing lower odds ratios for short and 
long IPI in women with a previous preterm birth. 
It is unclear the extent to which the reduction in relative associations observed for IPI after 
preterm birth reflect an underlying biological mechanism (as opposed to the alternative 
explanation of unmeasured confounding). The prevailing explanation for increased risk of 
adverse pregnancy outcomes after short IPI posits that shorter intervals allow insufficient time 
for women to recover from the physiological strain of the previous pregnancy (the maternal 
depletion hypothesis).27 Previous studies have reported mixed results regarding the effect of 
birth spacing on anthropometric status, anaemia, and micronutrient status as markers of 
nutritional depletion; the evidence is stronger for folate depletion as a potential causal 
mechanism.28 In the absence of biological measurements, our study is limited in its ability to 
assess maternal depletion as a causal mechanism; however, a greater relative association for 
short IPI after term birth is consistent with this hypothesis if longer gestation is associated with 
greater maternal depletion. Measurements of markers for physiological depletion (e.g. 
metabolic levels of folate) would be worthwhile in future studies of the interaction between IPI 
and previous gestational length to further explore this potential mechanism. Similarly, future 
research is required to identify potential biological mechanisms underlying a greater relative 
association of long IPI with PTB after a previous term birth. 
Consistent with a well-documented recurrence effect,29 women who had a previous preterm 
birth had a roughly four-fold increase in the absolute risks of PTB in the subsequent pregnancy 
(17-22% across IPIs) compared to women who had a previous term birth (3-6%) (Table 3). For 
women with a previous term birth, for whom we observed significantly larger odds ratios, low 
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baseline risk of PTB translated to a small increase in absolute risk associated with both short 
and long IPIs (2%). Conversely, for women with a previous preterm birth, smaller odds ratios 
translated to larger increases in absolute recurrence risk (4% for short IPIs; 5% for long IPs). 
In other words, where relative measures showed a greater association between IPI and PTB for 
women with previous term birth, absolute increases in risk were greater for women with 
previous preterm birth. Based on the relative measures, our results translate to a population 
attributable fraction (PAF) of 17.1% of PTB attributable to IPI for women with a previous term 
birth and a PAF of 9.4% of PTB attributable to IPI for women with a previous preterm birth. 
Therefore, IPI explains proportionally more cases of PTB among women with previous term 
birth than previous preterm birth, possibly due to the relatively smaller role of IPI involved in 
recurrent PTB, and the relatively more dominant role of other causes of recurrent PTB such as 
genetic factors and health-related behaviours unrelated to IPI. However, the absolute risk 
reduction of PTB at a population level is greater for women with previous preterm birth due to 
the much larger absolute risk of PTB among these women. 
Conclusion 
The literature documenting differences in the burden of adverse pregnancy outcomes 
associated with different IPIs is extensive.22 In recent years, studies have focussed primarily 
on disentangling confounding inherent in observational study designs,15 and on quantifying 
associations between IPI and a range of long-term outcomes.30 Evidence from matched study 
designs, in which greater control of confounding is possible, suggest that at a population 
level, any effect of short IPI is likely to be less than estimated by previous studies.15,31 
However, there is also an increasing recognition of the need for studies of the effect of IPI in 
high-risk groups, given that differences between subgroups may be obscured by population 
level analyses.25  A body of evidence evaluating differences in the associations according to 
obstetric context is emerging1,5,31, and may inform recommendations about IPI and reduce the 
14 
 
risk of harmful perinatal outcomes.3 This large international study found that the relative 
association between IPI and PTB is less for women experiencing preterm birth in the 
previous pregnancy, which for short IPI is consistent with maternal depletion. Furthermore, 
our results indicate that recurrence, not IPI, is the primary determinant of absolute risk. 
However, given high risk of recurrence and assuming a causal association between IPI and 
PTB, IPI remains a potentially modifiable risk factor for women with previous preterm birth. 
For women with previous term birth, decisions about birth spacing should also include 
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Table 1: Characteristics at second birth of mothers with first two consecutive singleton livebirths.  
 USA Australia  Norway Finland TOTAL 
 California WA NSW    
  (1991-2012) (1980-2015) (1995-2012) (1980-2015) (1987-2017) (1980-2017) 
 N % N % N % N % N % N % 
N             
Total 8,141,687 - 964,015 - 1,710,128 - 2,094,171 - 1,850,446 - 14,760,447 - 
Eligible* 1,809,836 22.2 254,511 26.4 387,244 22.6 601,413 28.7 521,885 28.2 3,574,889 24.2 
Included** 1,619,394 19.9 252,473 26.2 386,357 22.6 546,118 26.1 409,513 22.1 3,213,855 21.8 





        
Age (years)             
14-19 79,330 4.9 7,007 2.8 7,778 2.0 2,492 0.5 2,821 0.7 99,428 3.1 
20-24 370,343 22.9 47,004 18.6 56,349 14.6 80,597 14.8 61,000 14.9 615,293 19.1 
25-29 431,975 26.7 82,662 32.7 110,854 28.7 210,242 38.5 146,468 35.8 982,201 30.6 
30-34 449,269 27.7 78,705 31.2 135,130 35.0 184,726 33.8 139,436 34.0 987,266 30.7 
35-39 240,780 14.9 32,264 12.8 65,507 17.0 59,992 11.0 51,714 12.6 450,257 14.0 
40 or older 47,697 2.9 4,831 1.9 10,739 2.8 8,069 1.5 8,074 2.0 79,410 2.5 
              




       
  
1980-1984 - - 15,019 5.9 - - 23,369 4.3 - - 38,388 1.2 
1985-1989 - - 32,775 13.0 - - 68,402 12.5 8,973 2.2 110,150 3.4 
1990-1994 105,252 6.5 35,339 14.0 - - 80,390 14.7 67,803 16.6 288,784 9.0 
1995-1999 377,276 23.3 36,488 14.5  70,431 18.2 82,846 15.2 72,801 17.8 639,842 19.9 
2000-2004 422,619 26.1 35,998 14.3 112,344 29.1 86,341 15.8 69,210 16.9 726,512 22.6 
2005-2009 446,930 27.6 41,494 16.4 125,355 32.4 91,448 16.7 74,226 18.1 779,453 24.3 
2010-2014 267,317 16.5 45,923 18.2 78,227 20.2 94,570 17.3 75,950 18.5 561,987 17.5 
2015-2017 - - 9,437 3.7 - - 18,752 3.4 40,550 9.9 68,739 2.1 





       
  
Preterm birth 121,484 7.5 13,939 5.5 16,465 4.3 21,660 4.0 13,722 3.4 187,270 5.8 






       
  
Previous term 1,491,338 92.1 235,563 93.3 365,110 94.5 515,567 94.4 390,080 95.3 2,997,658 93.3 
Previous preterm 128,056 7.9 16,910 6.7 21,247 5.5 30,551 5.6 19,433 4.7 216,197 6.7 
Abbreviations: NSW = New South Wales; USA = United States of America; WA = Western Australia. 
* Mothers with first two consecutive singleton livebirths. 
** Excludes births with missing gestational age, birthweight or date of birth; gestational age <20 or 






Table 2: Pooled adjusted odds ratios for the outcome of PTB for IPI categories, stratified by previous 
term or preterm birth (mothers with first and second births). 











<6 months 1.50 (1.43-1.58) 54% 1.30 (1.18-1.42) 58% 0.006 
6-11 months 1.10 (1.04-1.16) 79% 1.03 (0.98-1.07) 0% 0.04 
12-17 months 1.00 (0.95-1.06) 80% 1.02 (0.97-1.08) 23% 0.60 
18-23 months (referent) 1 - 1 - - 
24-59 months 1.16 (1.13-1.18) 30% 1.12 (1.06-1.19) 49% 0.36 
≥60 months 1.72 (1.60-1.86) 88% 1.29 (1.17-1.42) 69% <0.001 
* Study-level odds ratios from prognostic score-stratified models. Prognostic score components: 
maternal age, birth year. 




Table 3: Pooled absolute risk of PTB for IPI categories, stratified by previous term or preterm birth 
(mothers with first and second births). 
 Previous Term Birth Previous Preterm Birth 
Risk difference %, 
95% CI 
(Preterm - Term) 
Interval 
Pooled absolute 
risk %, 95% CI 
Risk difference %, 
95% CI 
(Interval - 18-23 
months) 
Pooled absolute 
risk %, 95% CI 
Risk difference %, 
95% CI 
(Interval - 18-23 
months) 
 
<6 months 5.3 (3.4-8.0) 2.0 (-0.6-5.0) 22.4  (19.4-25.6) 5.4 (0.8-9.8) 17.1 (13.0-20.9) 
6-11 months 3.7 (2.3-5.9) 0.4 (-1.9-2.9) 17.8 (14.6-21.5) 0.8 (-3.9-5.6) 14.1 (10.2-18.1) 
12-17 months 3.3 (2.1-5.3) 0.0 (-2.1-2.3) 17.3 (14.4-20.6) 0.3 (-4.2-4.8) 14.0 (10.5-17.5) 
18-23 months 3.3 (2.1-5.0)  - 17.0 (14.0-20.5)  - 13.7 (10.2-17.4) 
24-59 months 3.8 (2.6-5.7) 0.5 (-1.6-2.7) 18.8 (16.3-21.6) 1.8 (-2.4-6.0) 15.0 (11.9-18.1) 
≥60 months 5.6 (4.0-7.8) 2.3 (0.0-4.8) 21.0 (18.3-23.9) 4.0 (-0.4-8.2) 15.4 (11.9-18.6) 
Abbreviations: CI = confidence interval; IPI = interpregnancy interval; PTB = preterm birth. 
 
